Delivery Order SPE2DB22D2211-SPE2DB25FRNAF

Award Date 12/31/24
Potential Completion Date 1/2/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,314.71 Firm Fixed Price Delivery Order covers the supply of 4,566,731,869 units of Cetirizine HCL 10 mg tablets in 100-count bottles, with a completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.64 firm fixed-price delivery order is for the supply of Cetirizine HCL 5 mg tablets in 100-count bottles. The contract has a completion date of May 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,896.20 firm fixed price delivery order is for the supply of 4,566,256,766 Cetirizine HCL 5 mg tablets in 100-count bottles. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,547.16 firm fixed price delivery order is for the supply of 4,564,906,871 Cetirizine HCl 5 mg tablets in 100-count bottles. The award has no set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,686.91 firm fixed-price delivery order covers the supply of 4,566,693,120 units of the drug Cetirizine HCL 10 mg tablets. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply Cetirizine Hydrochloride 5 mg tablets to the U.S. government. The Delivery Order contract, valued at $4,540.80, is a Firm Fixed Price arrangement with a completion date of June 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,880 units of Cetirizine HCL 10 mg tablets. The $8,582.74 firm fixed price contract has a completion date of February 9, 2023 and was awarded on February 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,567,379 units of 10 mg Cetirizine HCL tablets. The $13,146.34 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which covers a broad range of pharmaceutical and medical supply products in support of military healthcare...
The federal contract award was made to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, worth $7,791.41, is a Delivery Order from the Defense Logistics Agency (DLA) for the supply of 4,565,123,179 units of Cetirizine HCl 5 mg tablets. The contract has a performance period ending on July 12, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,936.70 issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides the delivery of 4559542757 - Cetirizine HCL 1 mg/ml solution, 120 ml. This order has a firm fixed price and an ultimate completion date of January 10, 2023. The contract does not have a set-aside designation, indicating open...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRNAF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,049.82 firm fixed-price delivery order covers the supply of Cetirizine HCl 5 mg tablets to support military healthcare programs. The award is not designated under any set-aside program.

Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military globally. This contract encompasses critical medical commodities across multiple therapeutic areas. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued at $750,000 for similar medical products and prescription drugs.

Generated 4/1/25, 10:58 AM